MICU1 and breast cancer: The averaged normalized height of TEPO at t_0 was 113% ± 8% and decreased to 94% ± 1% at t_2; that of PYRA was 104% ± 1% and decreased to 98 ± 1%; that of CALC at t_0 was 147% ± 4% and decreased to 89% ± 1%; and that of BC was 138% ± 8% and decreased to 85% ± 3%.